Host Response to Infection Panel

Beckman Coulter

United States

Beckman Coulter Diagnostics is a global leader in clinical laboratory diagnostics with over 90 years of experience in advancing diagnostic testing solutions. The company operates as a division of Danaher, a leading life sciences and diagnostics innovator. Beckman Coulter develops and manufactures diagnostic instruments and reagents used in hospitals, reference laboratories, research facilities, and physician offices worldwide. The company specializes in chemistry analyzers, immunoassay systems, hematology instruments, microbiology solutions, urinalysis platforms, and clinical information management systems. Key therapeutic areas include antimicrobial resistance management, host response to infection monitoring, cardiovascular disease diagnostics, diabetes management, neurodegenerative disease research, and sepsis detection. Beckman Coulter's products comply with the IVD Directive 98/79/EC and regulatory standards across major markets. The company emphasizes integrated workflow automation, digital laboratory solutions, and high-sensitivity diagnostic capabilities to improve clinical decision-making and patient outcomes globally.